These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1506348)

  • 41. The comparative activity of twelve 4-quinolone antimicrobials against Haemophilus influenzae and Streptococcus pneumoniae.
    Ridgway GL; O'Hare MD; Felmingham D; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(4):259-62. PubMed ID: 2941258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial activities of tosufloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella branhamella catarrhalis isolated from otolaryngological infectious diseases.
    Suzuki K; Fujisawa T; Nakashima M; Hamasaki R
    J Infect Chemother; 2005 Oct; 11(5):253-5. PubMed ID: 16258823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro antimicrobial activity of fluoroquinolones against clinical isolates obtained in 1989 and 1990.
    Chen YC; Chang SC; Hsu LY; Hsieh WC; Luh KT
    J Formos Med Assoc; 1993 Dec; 92(12):1040-8. PubMed ID: 7911351
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibacterial activity of tosufloxacin against fresh clinical isolates].
    Yamashiro Y; Shimakura M; Minami S; Fukuoka Y; Yasuda T; Watanabe Y; Narita H; Akama M
    Jpn J Antibiot; 1994 Mar; 47(3):245-54. PubMed ID: 8182895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
    Fernandes PB; Chu DT; Swanson RN; Ramer NR; Hanson CW; Bower RR; Stamm JM; Hardy DJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of tosufloxacin against bacterial enteric pathogens.
    Glick EJ; Segreti J; Goodman LJ; Trenholme GM
    Diagn Microbiol Infect Dis; 1990; 13(4):333-6. PubMed ID: 2076595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo antibacterial activities of a new quinolone, OPC-17116.
    Imada T; Miyazaki S; Nishida M; Yamaguchi K; Goto S
    Antimicrob Agents Chemother; 1992 Mar; 36(3):573-9. PubMed ID: 1320364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Nakai H; Sato T; Uno T; Furukawa E; Kawamura M; Takahashi H; Watanabe A; Fujimura S
    J Infect Chemother; 2018 Feb; 24(2):83-87. PubMed ID: 29290527
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The in-vitro activity and tentative breakpoint of gemifloxacin, a new fluoroquinolone.
    Wise R; Andrews JM
    J Antimicrob Chemother; 1999 Nov; 44(5):679-88. PubMed ID: 10552986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [In vitro activity of sitafloxacin against clinical isolates in 2012].
    Amano A; Matsuzaki K; Kishi N; Koyama H; Hasegawa M; Ikeda F; Matsumoto T; Yamaguchi H; Okutani Y
    Jpn J Antibiot; 2013 Dec; 66(6):311-30. PubMed ID: 24649797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The in vitro activity of BMS-284756, a new des-fluorinated quinolone.
    Weller TM; Andrews JM; Jevons G; Wise R
    J Antimicrob Chemother; 2002 Jan; 49(1):177-84. PubMed ID: 11751785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro antibacterial activities of the fluoroquinolones PD 117596, PD 124816, and PD 127391.
    Cohen MA; Huband MD; Mailloux GB; Yoder SL; Roland GE; Heifetz CL
    Diagn Microbiol Infect Dis; 1991; 14(3):245-58. PubMed ID: 1889177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro activity of DJ-6783 (a keto carboxylic acid) compared with six other orally administered antimicrobial agents.
    Jones RN; Ayers LW; Barry AL; Gerlach EH; Sommers HM; Thornsberry C; Fuchs PC
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):315-26. PubMed ID: 3698544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Newly documented antimicrobial activity of quinolones.
    Furet YX; Pechère JC
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):249-54. PubMed ID: 1864284
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN; Saxon B; Matsen JM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones.
    Hardy DJ; Swanson RN; Hensey DM; Ramer NR; Bower RR; Hanson CW; Chu DT; Fernandes PB
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1768-74. PubMed ID: 3435123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agents.
    Mandell W; Neu HC
    Antimicrob Agents Chemother; 1986 May; 29(5):852-7. PubMed ID: 3729343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative in-vitro activity of new quinolones against clinical isolates and resistant mutants.
    Rohner P; Peebo M; Lew DP; Auckenthaler R; Pechère JC
    J Antimicrob Chemother; 1992 Jan; 29(1):41-8. PubMed ID: 1737723
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.
    Fujimaki K; Noumi T; Saikawa I; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1988 Jun; 32(6):827-33. PubMed ID: 2843082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro susceptibility of Nocardia spp. to a new fluoroquinolone, tosufloxacin (T-3262).
    Yazawa K; Mikami Y; Uno J
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2140-1. PubMed ID: 2619279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.